Back to Journals » Drug Design, Development and Therapy » Volume 11

Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor

Total article views   Abstract views HTML views PDF downloads Totals
7,451 Dovepress* 5,972 990+ 840 6,962
PubMed Central* 0 489 177 489
Totals 5,972 1,479 1,017 7,451
*Since 16 October 2017
+Since July 2016

View citations on PubMed Central and Google Scholar